Provided by Tiger Fintech (Singapore) Pte. Ltd.

InfuSystems

4.85
+0.10002.11%
Post-market: 4.850.00000.00%16:05 EDT
Volume:67.37K
Turnover:325.77K
Market Cap:101.93M
PE:44.09
High:4.90
Open:4.78
Low:4.75
Close:4.75
Loading ...

InfuSystem to Report First Quarter 2025 Financial Results on May 8, 2025

Business Wire
·
01 May

Craig-Hallum Sticks to Their Buy Rating for InfuSystem Holdings, Inc. (INFU)

TIPRANKS
·
01 Apr

InfuSystem CEO Richard DiIorio to Step Down, Carrie Lachance Named Successor

MT Newswires Live
·
01 Apr

InfuSystem Holdings Inc - Affirms 2025 Revenue Growth Guidance of 8%-10%

THOMSON REUTERS
·
01 Apr

InfuSystem Holdings Inc - Richard Diiorio to Step Down as CEO Effective May 19, 2025

THOMSON REUTERS
·
01 Apr

InfuSystem Announces CEO Transition; Carrie Lachance to Become Chief Executive Officer

THOMSON REUTERS
·
01 Apr

InfuSystem Announces CEO Transition; Carrie Lachance to Become Chief Executive Officer

Business Wire
·
01 Apr

Are Options Traders Betting on a Big Move in InfuSystem (INFU) Stock?

Zacks
·
29 Mar

InfuSystems Holdings Inc (INFU) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com
·
05 Mar

Lake Street Keeps Their Buy Rating on InfuSystem Holdings, Inc. (INFU)

TIPRANKS
·
05 Mar

InfuSystems Holdings, Inc. (INFU) Misses Q4 Earnings and Revenue Estimates

Zacks
·
04 Mar

BRIEF-InfuSystem Announces Results for Fourth Quarter and Full Year 2024

Reuters
·
04 Mar

InfuSystem Estimates 2025 With Net Revenue Growth Of 8% To 10%, With Adjusted EBITDA Margin To Be In The High-Teens

Benzinga
·
04 Mar

InfuSystems Holdings Q4 2024 GAAP EPS $0.04 Misses $0.07 Estimate, Sales $33.85M Miss $34.90M Estimate

Benzinga
·
04 Mar

InfuSystem Q4 Gross Profit USD 18.216 Million

THOMSON REUTERS
·
04 Mar

InfuSystem Holdings Inc: 2025 Outlook Net Revenue Growth 8% -10%

THOMSON REUTERS
·
04 Mar

InfuSystem Holdings Inc: Q4 EPS $0.04

THOMSON REUTERS
·
04 Mar

InfuSystem Outlook FY Revenue Growth 8-10%

THOMSON REUTERS
·
04 Mar

InfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2024

Business Wire
·
04 Mar

Analysts Offer Insights on Healthcare Companies: MiMedx Group (MDXG), InfuSystem Holdings, Inc. (INFU) and Biodesix (BDSX)

TIPRANKS
·
03 Mar